hsk39004
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 2, 2024 (NCT06905847)
Timeline
Indications
Mechanism of action
- Phosphodiesterase isozyme 4INHIBITOR
PDE4 inhibitor
- Phosphodiesterase 3AINHIBITOR
PDE3A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07108699 | Phase 2 | Aug 13, 2025 | Haisco Pharmaceutical |
| NCT07140328 | Phase 2 | Apr 24, 2025 | Haisco Pharmaceutical |
| NCT06971198 | Phase 1 | Feb 10, 2025 | Haisco Pharmaceutical |
| NCT06905847 | Phase 1 | Sep 2, 2024 | Haisco Pharmaceutical |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Haisco Pharmaceutical | For profit | 4 | 4 | 2 | 2024 |
1 organizations
Page 1 / 1